Compare Cadila Healthcare with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TTK HEALTHCARE - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TTK HEALTHCARE CADILA HEALTHCARE/
TTK HEALTHCARE
 
P/E (TTM) x 31.3 10.9 288.3% View Chart
P/BV x 5.5 1.6 348.1% View Chart
Dividend Yield % 0.6 1.0 64.2%  

Financials

 CADILA HEALTHCARE   TTK HEALTHCARE
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
TTK HEALTHCARE
Mar-19
CADILA HEALTHCARE/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3521,215 29.0%   
Low Rs207610 33.8%   
Sales per share (Unadj.) Rs139.2444.4 31.3%  
Earnings per share (Unadj.) Rs11.817.2 68.2%  
Cash flow per share (Unadj.) Rs18.627.6 67.2%  
Dividends per share (Unadj.) Rs3.505.00 70.0%  
Dividend yield (eoy) %1.30.5 228.6%  
Book value per share (Unadj.) Rs101.4177.9 57.0%  
Shares outstanding (eoy) m1,023.7414.13 7,245.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.02.1 97.7%   
Avg P/E ratio x23.752.9 44.9%  
P/CF ratio (eoy) x15.033.0 45.6%  
Price / Book Value ratio x2.85.1 53.8%  
Dividend payout %29.829.0 102.6%   
Avg Mkt Cap Rs m286,03312,894 2,218.3%   
No. of employees `00013.42.3 579.8%   
Total wages/salary Rs m24,1451,307 1,847.4%   
Avg. sales/employee Rs Th10,632.72,715.7 391.5%   
Avg. wages/employee Rs Th1,801.2565.3 318.6%   
Avg. net profit/employee Rs Th898.5105.4 852.4%   
INCOME DATA
Net Sales Rs m142,5316,279 2,270.0%  
Other income Rs m1,13978 1,469.7%   
Total revenues Rs m143,6706,356 2,260.3%   
Gross profit Rs m24,198496 4,882.6%  
Depreciation Rs m6,965147 4,747.8%   
Interest Rs m3,41834 10,112.4%   
Profit before tax Rs m14,954393 3,809.0%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,198149 2,147.8%   
Profit after tax Rs m12,044244 4,942.1%  
Gross profit margin %17.07.9 215.1%  
Effective tax rate %21.437.9 56.4%   
Net profit margin %8.53.9 217.7%  
BALANCE SHEET DATA
Current assets Rs m87,1542,717 3,207.5%   
Current liabilities Rs m82,6941,571 5,264.5%   
Net working cap to sales %3.118.3 17.1%  
Current ratio x1.11.7 60.9%  
Inventory Days Days7132 222.1%  
Debtors Days Days9447 201.1%  
Net fixed assets Rs m133,236991 13,444.6%   
Share capital Rs m1,024141 724.7%   
"Free" reserves Rs m102,7332,373 4,329.3%   
Net worth Rs m103,7572,514 4,126.7%   
Long term debt Rs m32,1463 945,470.6%   
Total assets Rs m236,8664,158 5,696.5%  
Interest coverage x5.412.6 42.6%   
Debt to equity ratio x0.30 22,911.2%  
Sales to assets ratio x0.61.5 39.8%   
Return on assets %6.56.7 97.8%  
Return on equity %11.69.7 119.8%  
Return on capital %13.716.9 81.1%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m52,752225 23,424.5%   
Fx outflow Rs m14,50471 20,396.6%   
Net fx Rs m38,248154 24,821.9%   
CASH FLOW
From Operations Rs m25,054173 14,473.7%  
From Investments Rs m-10,12397 -10,490.2%  
From Financial Activity Rs m-10,942-307 3,560.7%  
Net Cashflow Rs m3,989-38 -10,580.9%  

Share Holding

Indian Promoters % 74.8 65.4 114.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 5.2 113.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 25.8 42.6%  
Shareholders   44,069 12,723 346.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NATCO PHARMA  PANACEA BIOTECH  FDC  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)

Aug 21, 2020 | Updated on Aug 21, 2020

For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 20, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS